$LH News

Labcorp And NACHC Announce Strategic Alliance To Support Practice Improvement And Advance Community Health Initiatives Across Community Health Center Network

Labcorp CEO Adam Schechter Sells 4,669 Shares for $1.5 Million

Is Labcorp Holdings (LH) Fully Priced Following Oncology Approvals And Raised Outlook?

Did Stronger Guidance, Buybacks and New Oncology Tests Just Shift Labcorp Holdings' (LH) Investment Narrative?

Labcorp Announces FDA Approval of Companion Diagnostic Supporting Patients with Advanced Melanoma

Labcorp Launches FDA-Approved PTEN Companion Diagnostic for Prostate Cancer

Labcorp Announces Availability of Roche's Ventana Pten RxDx Assay, First Immunohistochemistry Companion Diagnostic Test Approved By FDA To Determine Pten Protein Loss In Prostate Adenocarcinoma Patients

Labcorp (LH) Q2 2026 Earnings Call Transcript

Labcorp Holdings Inc. 2026 Q2 - Results - Earnings Call Presentation

JP Morgan Maintains Overweight on Labcorp Holdings, Raises Price Target to $360

Labcorp (LH) Launches Marker Genetic Health Panel For Consumer Testing

LH Q2 Deep Dive: Specialty Testing and Consumer Growth Drive Guidance Increase

Morgan Stanley Maintains Overweight on Labcorp Holdings, Raises Price Target to $338

Labcorp Q2 Earnings Call Highlights

Truist Securities Maintains Buy on Labcorp Holdings, Raises Price Target to $350

Barclays Maintains Equal-Weight on Labcorp Holdings, Raises Price Target to $320

Labcorp Holdings Inc. Q2 2026 Earnings Call Summary

Labcorp (LH) Q2 2026 Earnings Call Transcript

Labcorp Holdings Inc (LH) (Q2 2026) Earnings Call Highlights: Strong Revenue Growth and Raised ...

Labcorp Holdings Inc. (LH) Q2 2026 Earnings Call Transcript